NEW YORK (GenomeWeb News) – Trovagene and US Oncology Research today announced a deal for the use of Trovagene's technology to determine whether KRAS mutations can be evaluated in urine to monitor pancreatic cancer patients.
Registering provides access to this and other free content.
Already have an account?Login Now.
Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.
Popular Mechanics reports that Caltech researchers have built a prototype nanobot using DNA.
The Sacramento Bee writes that direct-to-consumer genetic testing connected a woman to sperm donor-conceived half siblings.
In PLOS this week: gene expression catalog for sheep, viral diversity among respiratory samples from camels, and more.